Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 143

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 143
---
 SHEET INFORMATIONComponents of selected captions within our accompanying unaudited consolidated balance sheets are as follows:Trade accounts receivable, net As of(in millions)September 30, 2025December 31, 2024Trade accounts receivable$2,961 $2,667 Allowance for credit losses(133)(109) $2,828 $2,558 

25

Table of Contents

The following is a roll forward of our Allowance for credit losses:Three Months Ended September 30,Nine Months EndedSeptember 30,(in millions)2025202420252024Beginning balance$112 $105 $109 $110 Credit loss expense28 10 49 30 Write-offs(7)(6)(25)(32)Ending balance$133 $109 $133 $109 Inventories As of(in millions)September 30, 2025December 31, 2024Finished goods$1,827 $1,798 Work-in-process245 193 Raw materials849 819  $2,921 $2,810 Other current assets As of(in millions)September 30, 2025December 31, 2024Restricted cash and restricted cash equivalents$98 $111 Derivative assets97 305 Other505 414  $701 $831 Property, plant and equipment, net As of(in millions)September 30, 2025December 31, 2024Land$147 $144 Buildings and improvements2,536 2,019 Equipment, furniture and fixtures4,036 3,630 Capital in progress936 1,035  7,656 6,827 Less: accumulated depreciation3,861 3,533  $3,795 $3,294 Depreciation expense was $117 million and $334 million for the third quarter and first nine months of 2025, respectively, and $102 million and $290 million for the third quarter and first nine months of 2024, respectively.Other long-term assets As of(in millions)September 30, 2025December 31, 2024Restricted cash equivalents$103 $80 Operating lease right-of-use assets495 449 Investments643 555 Indemnification asset212 188 Other380 481  $1,832 $1,754